Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Non Operating Income (2021 - 2023)

Historic Other Non Operating Income for Immuneering (IMRX) over the last 3 years, with Q4 2023 value amounting to $464352.0.

  • Immuneering's Other Non Operating Income rose 10797.03% to $464352.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 51531.85%. This contributed to the annual value of $1.3 million for FY2023, which is 51531.29% up from last year.
  • Per Immuneering's latest filing, its Other Non Operating Income stood at $464352.0 for Q4 2023, which was up 10797.03% from $475595.0 recorded in Q3 2023.
  • Immuneering's Other Non Operating Income's 5-year high stood at $475595.0 during Q3 2023, with a 5-year trough of -$118974.0 in Q4 2021.
  • For the 3-year period, Immuneering's Other Non Operating Income averaged around $142404.8, with its median value being $135514.0 (2022).
  • In the last 5 years, Immuneering's Other Non Operating Income soared by 159381.88% in 2022 and then surged by 10797.03% in 2023.
  • Over the past 3 years, Immuneering's Other Non Operating Income (Quarter) stood at -$118974.0 in 2021, then skyrocketed by 287.67% to $223278.0 in 2022, then soared by 107.97% to $464352.0 in 2023.
  • Its Other Non Operating Income stands at $464352.0 for Q4 2023, versus $475595.0 for Q3 2023 and $150193.0 for Q2 2023.